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Abstract
Background
Understanding the current epidemiology of malaria and the relationship between interven-
tion coverage, transmission intensity, and burden of disease is important to guide control
activities. We aimed to determine the prevalence of anemia, parasitemia, and serological
responses to P. falciparum antigens, and factors associated with these indicators, in three
different epidemiological settings in Uganda.
Methods and Findings
In 2012, cross-sectional surveys were conducted in 200 randomly selected households
from each of three sites: Walukuba, Jinja district (peri-urban); Kihihi, Kanungu district
(rural); and Nagongera, Tororo district (rural) with corresponding estimates of annual ento-
mologic inoculation rates (aEIR) of 3.8, 26.6, and 125.0, respectively. Of 2737 participants,
laboratory testing was done in 2227 (81.4%), including measurement of hemoglobin, parasi-
temia using microscopy, and serological responses to P. falciparum apical membrane anti-
gen 1 (AMA-1) and merozoite surface protein 1, 19 kilodalton fragment (MSP-119). Analysis
of laboratory results was restricted to 1949 (87.5%) participants aged 40 years. Preva-
lence of anemia (hemoglobin < 11.0 g/dL) was significantly higher in Walukuba (18.9%)
and Nagongera (17.4%) than in Kihihi (13.1%), and was strongly associated with decreas-
ing age for those 5 years at all sites. Parasite prevalence was significantly higher in
Nagongera (48.3%) than in Walukuba (12.2%) and Kihihi (12.8%), and significantly in-
creased with age to 11 years, and then significantly decreased at all sites. Seropositivity to
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AMA-1 was 53.3% in Walukuba, 63.0% in Kihihi, and 83.7% in Nagongera and was associ-
ated with increasing age at all sites. AMA-1 seroconversion rates strongly correlated with
transmission intensity, while serological responses to MSP-119 did not.
Conclusion
Anemia was predominant in young children and parasitemia peaked by 11 years across 3
sites with varied transmission intensity. Serological responses to AMA-1 appeared to best
reflect transmission intensity, and may be a more accurate indicator for malaria surveillance
than anemia or parasitemia.
Introduction
Malaria remains an important public health problem in sub-Saharan Africa, and is responsible
for over 10% of the overall disease burden [1]. In the past decade, increased donor financing
and widespread scale-up of malaria control measures, including distribution of long-lasting in-
secticide-treated bed nets (LLINs), indoor residual spraying (IRS) with insecticides, intermit-
tent presumptive treatment in pregnancy (IPTp), and prompt and effective treatment with
highly efficacious artemisinin-based combination therapies (ACTs), have substantially reduced
the malaria burden in several countries [2–7]. However, these gains have not been consistent
across Africa [8], and malaria-associated morbidity and mortality remains high in some coun-
tries, including Uganda [9–11].
In 2012, Uganda was ranked fourth highest in number of malaria cases reported globally,
and sixth in number of malaria-associated deaths [12]. Although the epidemiology of malaria
varies widely, some of the highest levels of malaria transmission in the world have been re-
corded in Uganda, and much of the population lives in high transmission areas [11]. Uganda
has made mixed progress towards implementing malaria control interventions in the past de-
cade. Ownership of at least one insecticide treated net (ITN) per household increased substan-
tially from 16% in 2006 to 60% in 2011, but national IRS coverage remains low (6–7%). In
2011, the proportion of pregnant women receiving two or more doses of intermittent preven-
tive treatment (IPTp) was only 25%, while the proportion of febrile children treated with arte-
mether-lumefantrine (AL), the first-line recommended treatment for uncomplicated malaria,
was 44%, up from 23% in 2006 [13,14]. Data documenting the impact of scaling-up of control
interventions on indicators of malaria burden in Uganda are limited. Only IRS has been associ-
ated with a reduction in malaria morbidity [15], and this benefit has been transient in areas
where IRS has not been sustained [16]. Some evidence suggests that despite modest improve-
ments in coverage of malaria control interventions, the burden of malaria may be increasing in
certain areas of Uganda [17].
Monitoring and evaluation of malaria control activities relies heavily on large, nationally
representative cross-sectional surveys. In Uganda, these include Demographic Health Surveys
(DHS) which have been conducted every 5 years since 2001 and a single Malaria Indicator Sur-
vey (MIS) conducted in 2009. Although all these surveys include estimates of coverage of ma-
laria control interventions, indicators of malaria burden are limited to anemia testing and, only
in the 2009 MIS, estimates of parasitemia. The annual entomological inoculation rate (aEIR) is
generally considered the ‘gold-standard’ measure of malaria endemicity and transmission in-
tensity, but is highly labour-intensive and rarely measured [18]. In areas of stable malaria trans-
mission, anemia has been used to monitor the impact of control interventions [19–21].
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Parasite prevalence in children aged 2–10 years provides an indirect measure of transmission
intensity across a range of malaria endemicities and is the most frequently measured malario-
metric index [22,23]. More recently, serological responses to malaria antigens have gained mo-
mentum as indicators of malaria transmission and infection risk, as seroprevalence reflects
cumulative malaria exposure [24]. Recent studies have capitalized on the relationship between
P. falciparum exposure and antibody responses to show that it is possible to estimate transmis-
sion intensity in a community by calculating seroconversion rates using age specific prevalence
of specific antimalarial antibodies, including those to apical membrane antigen 1 (AMA-1) and
merozoite surface protein 1, 19 kilodalton fragment (MSP-119) [25–27].
To better understand the current epidemiology of malaria in Uganda, cross-sectional sur-
veys to estimate coverage levels of control interventions and key malaria indicators, including
anemia, parasitemia, and serological responses to AMA-1 and MSP-119 were conducted in
three sub-counties with varying levels of transmission intensity based on concurrently mea-
sured estimates of aEIR.
Methods
Study design
This was a cross-sectional community survey conducted in three different epidemiological set-
tings in Uganda. A total of 200 households were recruited in each site, using a list of households
randomly generated from a census database. The surveys consisted of a household question-
naire and biomarker survey. Finger-prick blood samples, obtained from all children under fif-
teen years of age and from a random selection of age stratified adults, were collected for
measurement of hemoglobin, thick and thin blood smear, rapid diagnostic test (RDT) for ma-
laria, and to save on filter paper. The protocol for this trial is available as supporting informa-
tion (S1 Protocol).
Ethics statement
Ethical approval was obtained from the Makerere University School of Medicine Research and
Ethics Committee (REC REF 2011–203), the Uganda National Council for Science and Tech-
nology (HS 1074), the London School of Hygiene & Tropical Medicine Ethics Committee (Ref-
erence 6012), and the University of California, San Francisco Committee on Human Research
(Reference 027911). For all households fulfilling the selection criteria, written consent to partic-
ipate in the study was sought. Written informed consent was obtained from the next of kin,
caretakers, or guardians on behalf of the children enrolled in the study. Furthermore, written
assent was obtained from children aged 8 years and above to participate in the study.
Study sites
Cross-sectional surveys were conducted between January and June 2012 in three sub-counties
purposively chosen to represent varied malaria transmission settings in Uganda: Walukuba,
Jinja district; Kihihi, Kanungu district; and Nagongera, Tororo district (Fig. 1). In each sub-
county, entomological surveys were conducted from October 2011 – September 2012 using
monthly human landing catches to generate estimates of aEIR as previously described [28].
Malaria transmission at all three sites was perennial, with 2 annual peaks following the rainy
seasons. Walukuba is a peri-urban area near Lake Victoria in the south-central part of the
country with an estimated aEIR of 3.8 infectious bites per person per year. Kihihi is a rural area
in the south-western part of the country, with an estimated aEIR of 26.6. Nagongera is a rural
area in the south-eastern part of the country near the Kenyan border, with an estimated aEIR
Parasitemia, Anemia & Serologic Responses as Markers of Malaria Burden
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of 125.0. Key malaria control interventions in all three districts include use of LLINs, malaria
case management with ACTs, and IPTp with sulfadoxine-pyrimethamine. A single round of
IRS using lambda-cyhalothrin was conducted in Kanungu district in 2007 and a mass, commu-
nity-based campaign to distribute free ITNs was conducted in Tororo district in January 2011.
Enumeration and mapping of households
In 2011, all households and other key features in the study areas were enumerated and mapped
to generate a sampling frame for the surveys. A household was defined as any single permanent
or semi-permanent dwelling structure acting as the primary residence for a person or group of
people that generally cook and eat together. Household locations were mapped using hand-
held eTrex global positioning system (GPS) receivers (Garmin Ltd., Olathe, KS) and readings
were taken from the door of the household, if possible, or from a point that was most represen-
tative of the household.
Recruitment and enrolment
We enrolled 200 households from each site using a list randomly generated from the household
enumeration database using computer-generated random numbers. Study personnel con-
ducted door-to-door recruitment to identify those households with at least one adult house-
hold resident in sequential order according to the recruitment list. Residents not home during
the initial contact were re-visited on at least three other occasions before eliminating them
from the sample selection process.
When a household was identified, study personnel briefly described the purpose of the
study to the head of the household or any adult household member present at home in the ap-
propriate language. Households were included if: 1) an adult aged 18 years or older was the
head of the household, and 2) the head of the household agreed to provide informed consent.
Households were excluded if: 1) no adult resident was at home on more than 3 visits, and 2)
Fig 1. Map of study sites in Uganda.
doi:10.1371/journal.pone.0118901.g001
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the household was vacant. For all households fulfilling the selection criteria, written consent to
participate in the study was sought.
Study procedures
Upon enrolment, a household questionnaire, based on the Malaria Indicator Survey question-
naire developed by the Roll Back Malaria Monitoring and Evaluation Reference Group [29],
was administered to heads of households or their designate. The questionnaire was used to ob-
tain information on all household members, including age, gender, and relationship to the
head of the household. It was also used to collect information on ownership and use of bed
nets, and proxy indicators of wealth including ownership of assets and land, household con-
struction, and food security. Finger-prick blood samples were obtained from all children under
fifteen years of age, and from one randomly selected household member within the following
age categories: 15–24 years, 25–34 years, 35–44 years, 45–54 years, and> 55 years. Blood sam-
ples were used for measurement of hemoglobin, thick and thin blood smear, and storage on
filter paper.
Laboratory evaluations
Thick and thin blood smears were stained with 2% Giemsa for 30 minutes. Thick smears were
evaluated for the presence of parasitemia (asexual forms only) and gametocytes. Parasite densi-
ties were calculated by counting the number of asexual parasites per 200 leukocytes (or per
500, if the count was less than 10 parasites or gametocytes per 200 leukocytes), assuming a leu-
kocyte count of 8,000/ul. A smear was considered negative after reviewing 100 high-powered
fields. All positive thick blood smears had corresponding thin smears reviewed for species iden-
tification. For quality control, all slides were read by a second microscopist and a third reviewer
was used to settle any discrepant readings. Hemoglobin concentration was assessed using a bat-
tery-operated portable hemoglobinometer (HemoCue Ltd., Angelholm, Sweden) and estimated
to an accuracy of 1 g/dL.
Blood spots were collected onto filter papers (Whatman 3MM;Whatman, Maidstone, UK),
allowed to dry overnight and stored at -20°C with dessicant for serology studies. The recombi-
nant proteins P. falciparum AMA-1 (3D7) and MSP-119 (Wellcome genotype) were used as an-
tigens in indirect ELISA as previously described [30]. Briefly, antigens were coated on plates at
the concentration of 0.5 mg/mL in coating buffer and incubated at 4oC overnight. The plates
were washed in PBST, and blocked with 1% (w/v) skimmed milk solution for three hours.
After washing, samples were added in duplicate at a final dilution of 1:1,000 to each plate to-
gether with a pool of hyper immune serum and the plates were incubated overnight at 4oC.
The plates were washed and 50 μl of HRP-conjugated rabbit anti human IgG (DAKO, #P0214)
were added into each well and incubated for three hours. After a further series of washes, sub-
strate solution (OPD, Sigma #P8287, in PBS) was added and the reaction was allowed to devel-
op for 15–20 min before addition of stopping solution (2M H2SO4). The optical density was
read using an ELISA reader at 450 nm.
Data management and statistical analysis
Data were collected using hand-held computers which were programmed to include range
checks, structure checks and internal consistency checks. All statistical analyses were carried
out using Stata version 12 (STATA Corporation, College Station, TX). Malaria indicators of in-
terest were; 1) anemia defined as hemoglobin less than 11 g/dl, 2) parasitemia defined on the
basis of expert microscopy results as presence of any asexual parasites on thick blood smear, 3)
AMA-1 antibody seropositivity and, 4) MSP-119 antibody seropositivity. Raw optical density
Parasitemia, Anemia & Serologic Responses as Markers of Malaria Burden
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(OD) measurements were averaged and normalized against the positive control samples on
each plate. The cut-off for seropositivity was calculated, as previously described with a separate
cut-off value generated for each antigen [27]. Seroconversion rates were estimated by fitting a
simple reversible catalytic model to seroprevalence data for each antigen [24]. Analyses of ma-
laria indicators were limited to study participants aged 40 years or younger due to the relatively
limited number of observations, particularly in one site (Walukuba), and concerns about lack
of precision of analyses including participants above 40 years of age. Comparisons between the
sites for categorical variables were made using the Chi-squared or Fisher’s exact test and for
continuous variables using the t-test. Associations between risk factors of interest and binary
malaria indicators were made using multivariate generalized estimating equations stratified by
study site with adjustment for clustering of study participants within the same household. In
these models the relationships between age and malaria indicators were fitted using linear
splines. A household wealth index was created using principal component analysis of data
based on household’s dwelling unit ownership of various durable goods, land, and household
food security and then categorized into tertiles [31]. Graphical presentation of the relationships
between age and both the prevalence of anemia and parasitemia were made using lowess
smoothing.
Results
Participant characteristics and coverage of control interventions
At total of 200 households were surveyed from each sub-county, including 2737 study partici-
pants “Table 1”. The age and gender of participants were similar across the three sites. The ma-
jority of households in Nagongera, and over half in Walukuba and Kihihi, owned at least one
ITN. However, the proportion of households with at least one ITN per 2 residents was much
lower at the 3 sites. Only 5 households in Walukuba reported receiving IRS in the prior 12
months. The proportion of mothers who received 2 doses of SP for IPTp during their last
Table 1. Characteristics of study sites, households, and participants.
Category Characteristic Study Site
Walukuba Kihihi Nagongera
Transmission intensity aEIRa using human landing catches (95% CI) 3.8 (0–11.4) 26.6 (7.6–
49.4)
125 (72.2–
183)
Sample size Number of household 200 200 200
Number of study participants 797 948 992
Demographics of survey participants Female gender, n (%) 399 (50.1%) 499 (52.6%) 537 (54.1%)
Median age in years (IQR) 18 (6–28) 15 (6–30) 14 (6–32)
Coverage of malaria control
interventions
Households with at least 1 ITN, n (%) 115 (57.5%) 102 (51.0%) 157 (78.5%)
Households with at least 1 ITN per 2 residents, n (%) 57 (28.5%) 34 (17.0%) 71 (35.5%)
Households reporting IRS in the last 12 months, n (%) 5 (2.5%) 0 0
IPTp with  2 doses of SP during last pregnancyb, n/N (%) 30/85
(35.3%)
48/91 (52.8%) 31/78 (39.7%)
Use of ACT if received recent antimalarial treatmentc, n/N
(%)
24/32
(75.0%)
32/39 (82.1%) 49/63 (77.8%)
aAnnual entomological inoculation rate (measured Oct 2011 – Sept 2012)
bAmong women who reported giving birth in the previous 4 years
cAmong children under the age of 5 years with reported fever in the previous 2 weeks
doi:10.1371/journal.pone.0118901.t001
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pregnancy ranged from 35.3% in Walukuba to 52.8% in Kihihi. The use of ACTs for antimalar-
ial treatment was high ( 75%) at all sites. A total of 2227 (81.4%) participants underwent lab-
oratory testing, and of these, 1949 (87.5%) aged 40 years were included in the analysis of
laboratory results “Table 2”.
Anemia
Mean hemoglobin levels were generally high (> 12.0 g/dL) and severe anemia (hemoglobin<
8g/dL) was uncommon at all sites “Table 2”. The prevalence of anemia (hemoglobin< 11g/dL)
was highest in Walukuba, the site with the lowest EIR “Table 2”. In children under-five, preva-
lence of anemia was significantly lower in Kihihi (29.5%), than in Walukuba (40.7%, p = 0.03)
and Nagongera (49.4%, p<0.001). The probability of anemia was highest in children under-
five, decreasing sharply until approximately 10 years of age at all 3 sites (Fig. 2). Considering all
sites combined, the prevalence of anemia was 35.7% in those 5 years of age and 8.0% in
those 6–40 years of age (p<0.001). In the adjusted analysis, the prevalence of anemia was most
strongly associated with age “Table 3”. For children 5 years of age, the odds of anemia de-
creased greatly with increasing age at all the sites (ORs ranging from 0.47 to 0.70 per 1 year in-
crease in age). For participants aged 6–40 years there was a more gradual decrease in the
prevalence of anemia in Walukuba (OR 0.96 per 1 year increase) and Kihihi (OR 0.91 per 1
year increase in age). The association between anemia and other factors varied by site; in Kihihi
and Nagongera, participants with parasitemia were significantly more likely to be anemic, but
Table 2. Estimates of malaria indicators.
Category Characteristic Study Site
Walukuba Kihihi Nagongera
Sample size Number of participants selected for laboratory testing 631 788 808
Number of participants selected for laboratory testing  40 years
of age
582 682 685
Anemia testing Mean hemoglobin g/dL (SD) 12.6 (2.0) 12.8 (1.8) 12.6 (1.9)
Mean hemoglobin g/dL children < 5 years (SD) 11.3 (1.6) 11.7 (1.5) 10.9 (1.6)
Hemoglobin < 11 g/dL, n (%) 110 (18.9%) 89 (13.1%) 119 (17.4%)
Hemoglobin < 11 g/dL children < 5 years, n/N (%) 63/155 (40.7%) 54/183 (29.5%) 78/158 (49.4%)
Hemoglobin < 8 g/dL, n (%) 7 (1.2%) 4 (0.6%) 3 (0.4%)
Blood smear
results
Positive for any asexual parasitemia, n (%) 71 (12.2%) 87 (12.8%) 331 (48.3%)
Positive for any asexual parasitemia children 2–10 years, n/N (%) 38/233 (16.3%) 50/280 (17.9%) 189/317 (59.6%)
Geometric mean parasite density/μL 438 881 950
P. falciparum infectiona, n (%) 67 (94.4%) 85 (97.7%) 326 (98.5%)
Positive for any gametocytes, n (%) 15 (2.6%) 13 (1.9%) 102 (14.9%)
Seroprevalenceb AMA-1 seropositive, n/N (%) 309/580 (53.3%) 428/679 (63.0%) 565/675 (83.7%)
Median AMA-1 antibody titer (IQR) 87 (19–452) 209 (32–913) 709 (182–1887)
AMA-1 seroconversion rate (95% CI) 0.10 (0.09–0.12) 0.17 (0.14–0.19) 0.42 (0.36–0.49)
MSP1–19 seropositive, n/N (%) 173/544 (31.8%) 344/678 (50.7%) 310/679 (45.7%)
Median MSP1–19 antibody titer (IQR) 66 (40–170) 101 (40–539) 94 (41–458)
MSP1–19 seroconversion rate (95% CI) 0.036 (0.031–
0.043)
0.089 (0.078–
0.100)
0.064 (0.057–
0.073)
aOnly including those positive for asexual parasites
b No serology results obtain in 16 subjects for AMA-1 and 48 subjects for MSP1–19
doi:10.1371/journal.pone.0118901.t002
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ITN use and other factors were not significantly associated. In Walukuba, participants who
slept under an ITN the previous night were significantly less likely to be anemic.
Parasitemia
The prevalence of asexual parasitemia was significantly higher in Nagongera than the other
two sites (p<0.001 for both comparisons), but was comparable in Walukuba and Kihihi, de-
spite the difference in aEIR in the two sites “Table 2”. A similar pattern was seen for partici-
pants of all ages and children aged 2–10 years. Parasite prevalence increased with age, peaking
by 11 years, and declining thereafter in all sites (Fig. 3). In the adjusted analysis, age was the
only factor significantly associated with parasite prevalence “Table 4”. Although the parasite
prevalence was substantially higher in Nagongera compared to the other two sites across all
ages, the relationship between age and parasitemia was remarkably similar across all three sites.
Increasing age was significantly associated with an increased odds of parasitemia up to 11 years
of age (ORs ranging from 1.07 to 1.13 per 1 year increase in age) and then from 12–40 years in-
creasing age was significantly associated with a decreased odds of parasitemia (ORs ranging
from 0.89 to 0.92 per 1 year increase in age). Other factors, including gender, ITN use, and so-
cioeconomic status were not significantly associated with parasitemia.
AMA-1 antibodies
The antibody response to AMA-1, whether evaluated as seroprevalence, titer, or seroconver-
sion rate, increased with increasing transmission intensity “Table 2”. Seroprevalences to AMA-
1 were 53.3% in Walukuba, 63.0% in Kihihi and 83.7% in Nagongera (p<0.001 for all compari-
sons). AMA-1 seroconversion rates were 0.10, 0.17, and 0.42, which, based on prior calibration,
corresponded to calculated aEIRs of 3, 9, and 121 for Walukuba, Kihihi, and Nagongera, re-
spectively. Peak seroprevalences were proportionate to the level of transmission intensity and
the age at which the peak was reached was inversely proportional to transmission intensity
Fig 2. Prevalence of anemia (hemoglobin< 11.0 g/dL) by age, in three different epidemiological
settings in Uganda.
doi:10.1371/journal.pone.0118901.g002
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(Fig. 4). In the adjusted analysis, increasing age was associated with increased odds of seroposi-
tivity to AMA-1 up to 10 years of age at all three sites with the strength of this association in-
creasing with increasing transmission intensity “Table 5”. In Nagongera, seropositivity to
AMA-1 peaked by 10 years of age but continued to increase significantly from 11–20 years of
age in Walukuba and Kihihi. Parasitemia was strongly associated with AMA-1 seropositivity at
all sites “Table 5”. In Walukuba only, gender and socioeconomic status were also significantly
associated with AMA-1 seropositivity, with significantly higher odds for females, and signifi-
cantly lower odds for those participants of highest socioeconomic status.
MSP-119 antibodies
Seroprevalences of antibodies to MSP-119, median MSP-119 antibody titers, and seroconversion
rates were lower than with AMA-1 and demonstrated different patterns across the three sites
“Table 2”. Seropositivity to MSP-119 was highest in Kihihi, and was significantly lower in
Walukuba (31.8%), than in Kihihi (50.7%, p<0.001) and Nagongera (45.7%, p<0.001). MSP-
119 seroconversion rates were 0.036, 0.089, and 0.064 for Walukuba, Kihihi, and Nagongera, re-
spectively, which corresponded to calculated aEIRs of 2 in Walukuba and 11 in Kihihi, but
only 6 in Nagongera, much lower than the aEIR actually observed (125) [30]. In the adjusted
analysis, there was an inconsistent relationship between age and seropositivity to MSP-119 up
to 3 years of age across the 3 sites “Table 6”. From 4–20 years of age there was a consistent and
significant relationship between increasing age and increasing seropositivity to MSP-119 and
no significant relationship from 21–40 years of age across the 3 sites. Only in Walukuba was
parasitemia significantly associated with seropositivity to MSP-119 “Table 6”.
Discussion
In this study, we evaluated the prevalence of key malaria indicators and associated factors in
three different epidemiological settings in Uganda. The prevalence of anemia was predominant
Fig 3. Prevalence of parasitemia (blood slide positive) by age, in three different epidemiological
settings in Uganda.
doi:10.1371/journal.pone.0118901.g003
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in the youngest children at all sites and did not correlate well with the level of transmission in-
tensity. Severe anemia was uncommon at all sites. The prevalence of parasitemia was highest in
Nagongera, the highest transmission site, but results were similar in Walukuba and Kihihi, de-
spite an almost ten-fold difference in aEIR. The relationship between age and parasite preva-
lence was similar at all three sites, increasing with age until peaking by 11 years and then
decreasing with age. Seroprevalence and seroconversion rates of antibodies to AMA-1 ap-
peared to best reflect differences in transmission intensity between the three sites. In contrast,
seropositivity of antibodies to MSP-119 did not follow a consistent pattern with age, and the se-
roconversion rate was unexpectedly low in Nagongera.
Fig 4. Seroconversion to AMA-1and MSP-119 by age, in three different epidemiological settings in Uganda.
doi:10.1371/journal.pone.0118901.g004
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Despite the recent increase in donor financing and focus on scaling-up of available malaria
control interventions, including ITNs, IRS, IPTp, and treatment with ACTs, coverage levels re-
main far below targets in Uganda. Although ownership and usage of ITNs has increased sub-
stantially in Uganda in the past decade, and ITN distribution has been extended beyond the
traditional target groups of children under-five and pregnant women with the recent shift in
policy to universal coverage, we found that 35% of households in the 3 study sites own
enough ITNs to cover the household population (one ITN per two residents). Fortunately,
Uganda is currently undertaking a national ITN distribution campaign aiming to achieve uni-
versal net coverage for the whole country. The same is true for IRS, which was reinstated as a
malaria control measure in Uganda in 2006, after a hiatus of about 40 years. Supported by the
US President’s Malaria Initiative and other partners, Uganda’s IRS strategy has emphasized im-
plementation in epidemic-prone areas, high-risk situations, such as camps for internally dis-
placed persons or refugees, and more recently, high-transmission areas [32]. But resources for
IRS are limited and only a few districts in Uganda benefit from this control strategy. Similarly,
coverage of IPTp remains low. We found that the proportion of mothers who received 2
doses of SP for IPTp during their last pregnancy ranged from 35–53% in the 3 sites; this is
below targets, but higher than the estimate of national IPTp coverage (25%) measured in the
2011 DHS survey. On a more positive note, the majority ( 75%) of febrile children under-five
received ACTs for antimalarial treatment, consistent with results from recent national surveys,
suggesting increased access and availability of ACTs in Uganda.
Although the etiology of anemia in tropical areas is multifactorial, P. falciparummalaria is
commonly associated with anemia in children living in holoendemic malaria areas [21,33–35].
We found that anemia was age-dependent at the 3 sites, as reported in other studies [36]. How-
ever, the prevalence of anemia did not correlate with the transmission intensity of the sites, and
in fact, was highest in Walukuba, the site with lowest transmission. Reasons for this finding are
unclear although schistosomasis or hookworm infection may have contributed. There is a com-
plex interplay between anemia, malaria parasitemia, red blood cell disorders, intestinal hel-
minths and malnutrition, however available data seems to suggest that malaria parasitemia is
the significant risk factor for anaemia [37,38]. Parasitemia was an independent predictor of
anemia at the higher transmission sites of Kihihi and Nagongera, suggesting that malaria plays
a role in the burden of anemia in higher transmission settings. This finding is supported by
prior studies demonstrating that children living in areas with very high malaria transmission
carry a markedly higher burden of anemia and febrile malaria episodes [39,40]. However, we
found that severe anemia (hemoglobin< 8.0 g/dL) was uncommon, even in Nagongera, the
highest transmission site. In Uganda, the prevalence of anemia, including moderate to severe
anemia, in children under-five has declined steadily since 2000, despite the persisting burden
of malaria in the country. Although childhood anemia remains an important metric of overall
child health, it is possible that malaria may no longer be the primary contributor to anemia in
Ugandan children in all settings, raising the question of whether anemia should continue to be
used as a metric of malaria-specific disease burden.
Parasite prevalence, particularly in children aged 2–10 years, is a commonly used measure
of malaria transmission intensity and disease burden across a range of endemicities [22,23].
However, parasite prevalence is affected by seasonal variation in transmission levels, survey
timing, and peak transmission seasons, and may be best considered a short-term measure of
malaria [24]. In addition, parasite prevalence has a complex relationship with age and may be
influenced by host immunity and use of antimalarial drugs. We found that prevalence of asexu-
al parasitemia was significantly higher in Nagongera, but was comparable in Walukuba and
Kihihi, despite the difference in aEIR in the two sites, suggesting that parasite prevalence did
not reflect the difference in transmission at the two lower intensity sites. Furthermore, we
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found that compared to previous surveys parasite prevalence appears to be increasing in
Nagongera, decreasing in Walukuba, and is relatively unchanged in Kihihi. Measuring malaria
parasite prevalence over time is challenging because malaria transmission dynamics are sensi-
tive to climatic variability [41] and are heterogeneous over small areas [42], complicating inter-
pretation of trends. Fluctuations in climate patterns over several years may also contribute to
similar fluctuations in parasite prevalence levels (inter-annual variation) which could mask
successes or lapses in malaria control efforts. Thus, although parasite prevalence is arguably
the most direct measure of malaria burden, it has several limitations and may not be able to ac-
curate classify the full spectrum of transmission intensity or track temporal changes.
Serological markers are useful adjunct measures of transmission as antibodies can persist
for months or years after infection, thereby smoothing out the effects of seasonal or unstable
malaria transmission [43] and represent cumulative exposure to infection. At our study sites,
antibodies to AMA-1 consistently increased with increasing aEIR with a good correlation be-
tween seroconversion rates and measured aEIR. AMA-1 seropositivity increased with age,
reaching a higher peak at a younger age as the level of transmission intensity increased. These
results support the utility of the prevalence, magnitude and rate of acquisition of antibodies to
AMA-1 as a reliable marker of the level of transmission as has been observed previously
[22,30]. However, in this setting, antibody responses to MSP-119 did not follow the same pat-
tern; antibody prevalence decreased in the first 5 years of life and the seroconversion rate was
surprisingly low for the high transmission site of Nagongera. The former may be due to a com-
bination of short-term fluctuations in transmission and high density parasite infections in
some young children. Antibody responses to MSP-119 have recently been shown to be more af-
fected by seasonal changes in transmission [44]. The unexpectedly low seroconversion rate to
MSP-119 in Nagongera is consistent with observations in other hyperendemic settings in
Uganda and elsewhere [45]. The reasons for this are unclear but a possible explanation may be
down-regulation of the immune response at very high transmission levels.
This study was conducted in areas with varying malaria transmission, and the findings may
apply in areas of similar transmission patterns. The concurrent measurement of aEIR, parasite
prevalence and serology enabled us to compare malariometric indices across different en-
demicity settings. However, studies were conducted at only 3 sites and we could not assess the
trends nor draw firm conclusions on causality because of the cross sectional design. Nonethe-
less, such surveys are important for tracking temporal trends of malariometric indices and
could be used to measure the impact of control interventions.
In summary, we found that coverage of malaria control interventions remains below targets
in these 3 sites in Uganda. Although anemia and parasite prevalence are widely used indicators
of the burden of malaria, we found that they did not directly correlate with transmission inten-
sity in our study sites. Seroprevalence of AMA-1 was a better marker of infection risk and dis-
ease burden and may be a better indicator than anemia or parasitemia for monitoring and
evaluation of trends in malaria burden and the impact of malaria control activities.
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